SYNERGY: Open Study of Enoxaparin Versus Unfractionated Heparin in Patients With Acute Coronary Syndromes

Clinical Trial ID NCT00043784

PubWeight™ 2.54‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00043784

Top papers

Rank Title Journal Year PubWeight™‹?›
1 High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial. JAMA 2005 1.52
2 Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease. JACC Cardiovasc Interv 2008 1.02
3 The impact of postrandomization crossover of therapy in acute coronary syndromes care. Circ Cardiovasc Qual Outcomes 2011 0.75
Next 100